Table 1.
Clinicopathological characteristics and expression of miR-98 in breast cancer
| characteristics | cases | miR98 expression level | ||
|---|---|---|---|---|
|
|
||||
| Low | high | p | ||
| Age (years) | ||||
| ≤40 | 18 | 12 | 6 | 0.324 |
| 40-55 | 33 | 15 | 18 | |
| >55 | 47 | 23 | 24 | |
| Histological grade | 0.599 | |||
| I | 7 | 3 | 4 | |
| II | 39 | 18 | 21 | |
| III | 52 | 29 | 23 | |
| Tumor stage | 0.548 | |||
| I | 18 | 6 | 12 | |
| II | 11 | 4 | 7 | |
| III | 5 | 3 | 2 | |
| N stage | 0.628 | |||
| 0 | 58 | 28 | 30 | |
| 1-3 | 22 | 12 | 10 | |
| 4-9 | 9 | 6 | 3 | |
| >10 | 8 | 3 | 5 | |
| ER status | 0.513 | |||
| negative | 40 | 22 | 18 | |
| positive | 58 | 28 | 30 | |
| PR status | 0.529 | |||
| negative | 44 | 24 | 20 | |
| positive | 54 | 26 | 28 | |